John Tchelingeria
Biomedical sciences
Promethera Bioscience
Belgium
Biography
Promethera Biosciences appointed Dr John Tchelingerian as its Chief Executive Officer in September, 2015. He initially joined the company as Chairman of the Board end of 2014, and acted as its interim CEO since January, 2015 and up to September, 2015. With the appointment of a new Chairman of the Board in June 2016, John now focusses entirely on his role of CEO, in combination with his Board duties as Series A representative Director.
Research Interest
Research development
